Nuvrumetinib

(Synonyms: PAS-004)

Nuvrumetinib (PAS-004) is a macrocyclic MEK inhibitor. Nuvrumetinib functionally inhibits MEK1/2, thereby suppressing pERK in tumors. Nuvrumetinib inhibits the proliferation of NRAS-mutant cancer cells. Nuvrumetinib can be used in studies related to NRASG12C-mutant solid tumors, neurofibromatosis type 1 (NF1), RASopathies and laminopathies.

For research use only. We do not sell to patients.

  • CAS No.: 3079099-31-0
  • Formula: C19H18F3IN2O5S
  • Molecular Weight:570.32
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00